MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-18-0032697
Glendale Biomed Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹30.54 Cr
▲ 51% YoY
Net profit · FY 2023
₹1.3 Cr
Net margin 4.3%
EBITDA · FY 2023
₹2.79 Cr
EBITDA margin 9.1%
Authorised capital
₹2.2 Cr
Registered with MCA
Paid-up capital
₹2.2 Cr
Issued & subscribed
Open charges
₹3.47 Cr
Satisfied ₹5.1 Cr
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
About Glendale Biomed Private Limited
Data last updated:
Glendale Biomed Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74120MH2016PTC273873. Its GSTIN is 27AAGCG3590G1ZH (Maharashtra).
The company has an authorised share capital of ₹2.2 Cr and a paid-up capital of ₹2.2 Cr. It is led by directors Pramod Yadav and Suraj Prakash Singh.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2023, the company reported a revenue of ₹30.54 Cr, a growth of 51% compared to the previous year. For the same year it recorded a net profit of ₹1.3 Cr (net margin 4.3%) and EBITDA of ₹2.79 Cr (EBITDA margin 9.1%). Revenue has grown at a compounded annual rate (CAGR) of 30% over three years and 19% over five years.
Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Glendale Biomed. As per MCA filings, the company has open charges of ₹3.47 Cr and satisfied charges of ₹5.1 Cr on record. Court records list 34 cases involving the company, including 5 filed by the company and 29 filed against it; 29 cases are pending. The company has 4 deals on record (3 secondary share transfers, 1 rights issue); the latest was in March 2021. Its 5 peer companies in the Pharma industry (Formulations), with the same principal business activity (wholesale trading) are compared by revenue, 3 larger and 2 smaller; the largest is Krish Chemicals Private Limited with revenue of ₹31.02 Cr.
Glendale Biomed Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0032697). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website glendalebiomed.com.
Company details
CIN U74120MH2016PTC273873
Registration Number 273873
Incorporation Date 04 March 2016
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-18-0032697
Recognitions & Rankings of Glendale Biomed
Contact details
Glendale Biomed Private Limited's registered office is in Mumbai, Maharashtra. Its website is glendalebiomed.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address204 – E B – Wing Sumit Samarth Arcade Tatya Tope Nagar Aarey Road Goregaon (, West), Mumbai, Maharashtra, India – 400062
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Glendale Biomed Private Limited, buy the company report.
Comprehensive company report
Glendale Biomed Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Glendale Biomed operates one associated brand: Glendale Biomed. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| A pharmaceutical company providing a diverse range of products for domestic distribution. | glendalebiomed.com |
Business activity
The main business activity of Glendale Biomed is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Glendale Biomed Private Limited, buy the company report.
Financials of Glendale Biomed Private Limited
FY 2023 filings availableGlendale Biomed Private Limited reported revenue of ₹30.54 Cr (up 51% YoY) for FY 2023.
Revenue · FY 2023
₹30.54 Cr ▲ 51%
Net profit · FY 2023
₹1.3 Cr margin 4.3%
EBITDA · FY 2023
₹2.79 Cr margin 9.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 51%
3 years · compounded
▲ 30%
5 years · compounded
▲ 19%
EBITDA CAGR growth
1 year
▲ 145%
3 years · compounded
▲ 101%
5 years · compounded
▲ 62%
Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 51% growth in the latest year. EBITDA rose 145% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹30.54 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.79 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.3 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.1% | ||||
| Net Profit Margin | 4.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Glendale Biomed Private Limited, buy the company report.
Board of directors of Glendale Biomed Private Limited
Glendale Biomed has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suraj Prakash Singh Also directs: Glendale Organics Private Limited, Carbonium Chem Private Limited | Additional Director | 20 Apr 2020 | 6 Years 6 Months | Current |
| Pramod Yadav Also directs: Glendale Organics Private Limited | Director | 15 Dec 2017 | 8 Years 10 Months | Current |
Peer comparison
Glendale Biomed Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Krish Chemicals Private Limited | ₹31.02 Cr (FY 2024) | 4.0% | Sarigam, Gujarat, India | |||
| Delvin Formulations Private Limited | ₹30.87 Cr (FY 2023) | 26.0% | Kanchipuram, Tamil Nadu, India | |||
| Algen Healthcare Limited | ₹30.69 Cr (FY 2025) | 5.0% | Delhi, India | |||
| Glendale Biomed Private Limitedthis company | ₹30.54 Cr (FY 2023) | ₹1.3 Cr | 4.3% | 51.0% | Mumbai, Maharashtra, India | |
| Hauz Pharma Private Limited | ₹30.46 Cr (FY 2024) | 14.0% | Chandigarh, India | |||
| Libraw Pharma Excipients Private Limited | ₹30.37 Cr (FY 2025) | 12.0% | New Delhi, Delhi, India |
To see the full peer comparison of Glendale Biomed Private Limited, buy the company report.
Auditor
Glendale Biomed Private Limited is audited by BHAVIN DEDHIA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BHAVIN DEDHIA & ASSOCIATES | FY 2023 | 150535 |
Shareholding
The shareholding of Glendale Biomed Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Glendale Biomed Private Limited, buy the company report.
Charges & borrowings
Open charges
₹3.47 Cr
Satisfied charges
₹5.1 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Nov 2022 | 100644111 | Others | ₹92 Lakh | Open | |
| 20 Jun 2022 | 100586261 | Others | ₹65 Lakh | Open | |
| 28 Jul 2021 | 100468639 | Canara Bank | ₹1.9 Cr | Open | |
| 31 Dec 2020 | 100439606 | Others | ₹35 Lakh | Satisfied | |
| 05 Jul 2019 | 100276653 | Others | ₹4.75 Cr | Satisfied |
To see the full charge records of Glendale Biomed Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Glendale Biomed Private Limited has 4 deals on record (3 secondary share transfers, 1 rights issue); the latest was in March 2021.
Total deals
4
Secondary share transfers
3
Rights issue
1
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Sep 2018 | Rights issue | ₹49 Lakh | Investors: 2 individuals |
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Glendale Biomed Private Limited has 34 court cases on record: 5 filed by Glendale Biomed, 29 filed against it. 29 cases are pending and 5 are disposed.
Total cases
34
Filed by the company
5
Filed against the company
29
Pending
29
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 28 | 28 | 25 |
| NCLAT | 5 | 0 | 4 |
| High courts | 1 | 1 | 0 |
Cases on record (5 of 34)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Court case (CHAMBER SUMMONS) | Filed against the company by Clearfast Air Cargo Agencies Pvt Ltd Through Ashwini Nandkumar Mene | Pending |
| NCLAT, NCLAT New Delhi | Interim or miscellaneous application | Filed by the company against Tulip Lab Private Limited | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Commercial matter | Filed against the company by Clearfast Air Cargo Agencies Pvt Ltd Through Ashwini Nandkumar Mene | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Secu. Case) | Filed against the company by Mangal Credit and Fincorp Limited Through Authorised Officer Bhavin Sindhwa | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed against the company by M/S Mangal Credit and Fincorp Limited Through Authorised Representative Mr Bhavin Sindhwa | Pending |
To see the full case history of Glendale Biomed Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Glendale Biomed Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Glendale Biomed has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Glendale Organics Private Limited | U24304MH2021PTC370726 |
To see the full group structure of Glendale Biomed Private Limited, buy the company report.
GST
Glendale Biomed has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCG3590G1ZH | Maharashtra | Active | 08 Dec 2017 |
To see the full GST registrations and return filing status of Glendale Biomed Private Limited, buy the company report.
Recent activity
Glendale Biomed Private Limited has 8 board changes on record since 2017: 2 appointments and 6 cessations. The latest: Ved Prakash ceased to be Director on 10 Apr 2021.
AGM
Glendale Biomed Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Glendale Biomed Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
Charges
A charge with Others amounted to Rs. 0.92 Cr with Charge ID 100644111 was registered on 02 Nov 2022.
Charges
A charge with Others amounted to Rs. 0.65 Cr with Charge ID 100586261 was registered on 20 Jun 2022.
Charges
A charge registered on 05 Jul 2019 via Charge ID 100276653 with Others was fully satisfied on 08 Oct 2021.
Charges
A charge registered on 31 Dec 2020 via Charge ID 100439606 with Others was fully satisfied on 15 Sep 2021.
Charges
A charge with Canara Bank amounted to Rs. 1.90 Cr with Charge ID 100468639 was registered on 28 Jul 2021.
Charges
A charge with Canara Bank of Rs. 1.90 Cr registered on 28 Jul 2021 with Charge ID 100468639 was modified on 28 Jul 2021.
Ceased
Ved Prakash ceased to be Director.
Charges
A charge with Others amounted to Rs. 0.35 Cr with Charge ID 100439606 was registered on 31 Dec 2020.
Appointed
Suraj Prakash Singh was appointed as Additional Director.
Charges
A charge with Others amounted to Rs. 4.75 Cr with Charge ID 100276653 was registered on 05 Jul 2019.
8 earlier events are in the company report.
Frequently asked questions
Glendale Biomed is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 March 2016 (10+ years old) and is registered under CIN U74120MH2016PTC273873.
Glendale Biomed has 2 current directors:
- Suraj Prakash Singh - Additional Director
- Pramod Yadav - Director
The latest financial statements of Glendale Biomed on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Glendale Biomed is 27AAGCG3590G1ZH, registered in Maharashtra.
The CIN (Corporate Identification Number) of Glendale Biomed is U74120MH2016PTC273873. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Glendale Biomed has 34 court cases on record: 5 filed by the company and 29 filed against it. 29 are pending. Most are in the district courts.
Glendale Biomed was incorporated on 04 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
Glendale Biomed has 4 deals on record (3 secondary share transfers, 1 rights issue); the latest was in March 2021.
The peers of Glendale Biomed by revenue are Krish Chemicals Private Limited, Delvin Formulations Private Limited, Algen Healthcare Limited, Hauz Pharma Private Limited, Libraw Pharma Excipients Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Ved Prakash ceased to be Director on 10 Apr 2021. Suraj Prakash Singh was appointed as Additional Director on 20 Apr 2020. Pramod Yadav ceased to be Additional Director on 29 Sep 2018. Glendale Biomed has 8 board changes on record in total.
Yes, Glendale Biomed is registered as a small enterprise under Udyam registration (number: UDYAM-MH-18-0032697).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages